ELIXIRGEN THERAPEUTICS, INC.

Profile

Company Names

ELIXIRGEN THERAPEUTICS, INC.

Addresses

855 N. WOLFE ST., SUITE 624, BALTIMORE, MD 21205

855 N. WOLFE STREET, SUITE 624, BALTIMORE, MD 21205

855 N. WOLFE ST., SUITE 619, BALTIMORE, MD 21205

Phone Numbers

443-451-5300
(443)869-5420
443-869-5420

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$34,106,860.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2025-10-30 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
7
2025-03-31 
$3,600,000.00 
$3,600,000.00 
$0.00 
Debt 
6
2025-01-30 
$600,000.00 
$600,000.00 
$0.00 
Debt 
5
2023-11-09 
$6,999,988.00 
$6,999,988.00 
$0.00 
Equity 
4
2022-09-14 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
3
2021-02-02 
$4,199,985.00 
$5,499,971.00 
$1,299,986.00 
Equity 
2
2019-11-19 
$5,706,889.00 
$5,706,889.00 
$0.00 
Equity 
1
2018-06-13 
$3,999,998.00 
$3,999,998.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHAUNA 
 
CALLAHAN 
DIRECTOR
MARKET FORCE INFORMATION INC   |  ELIXIRGEN THERAPEUTICS, INC.
JEFFREY 
 
CLELAND 
DIRECTOR
VERSARTIS, INC.   |  GRAYBUG LLC   |  GRAYBUG, INC.   |  ASHVATTHA THERAPEUTICS, LLC   |  ORPHERIS, INC.   |  GRAYBUG VISION, INC.   |  ASHVATTHA THERAPEUTICS, INC.   |  ELIXIRGEN THERAPEUTICS, INC.
MAIKO 
 
KATADAE 
DIRECTOR
ELIXIRGEN THERAPEUTICS, INC.
AKIHIRO 
 
KO 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ELIXIRGEN THERAPEUTICS, INC.
AKIHIRO 
C 
KO 
EXECUTIVE OFFICER, DIRECTOR
ELIXIRGEN THERAPEUTICS, INC.
MINORU 
 
KO 
DIRECTOR, EXECUTIVE OFFICER
ELIXIRGEN THERAPEUTICS, INC.
MINORU 
S.H. 
KO 
DIRECTOR
ELIXIRGEN THERAPEUTICS, INC.
HIROAKI 
 
KOBAYASHI 
DIRECTOR
ELIXIRGEN THERAPEUTICS, INC.
NAONORI 
 
KUROKAWA 
DIRECTOR
ELIXIRGEN THERAPEUTICS, INC.
THOMAS 
 
WHITE 
DIRECTOR
FIRST CALL VENTURES, LLC   |  INFINIA CORP   |  PHYNDER, INC.   |  C-SUITE HOLDINGS, LLC   |  PHYND TECHNOLOGIES, INC.   |  FIRST PARAGOULD BANKSHARES INC   |  SOVIERO OFFSHORE FUND, LTD.   |  ELIXIRGEN THERAPEUTICS, INC.   |  ACUMINO, INC.
THOMAS 
K. 
WHITE 
DIRECTOR
ELIXIRGEN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-10-30 
2025-04-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-03-31 
2025-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-01-30 
2023-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-09 
2022-09-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-09-14 
2021-02-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-02 
2020-08-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-19 
2019-12-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-19 
2018-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#